Ahmad A. AlTuwaijri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ahmad A. AlTuwaijri has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Alabdulqader
Department of Otolaryngology, Head and Neck Surgery, College of Medicine, Imam Mohammad Ibn Saud Islamic University , Uthman Ibn Affan Rd, An Nada, Riyadh 13317
1 shared publication Alanoud A. Abuhaimed
From the Department of Otolaryngology-Head and Neck Surgery (Altuwaijri Alessa, Aldhahri, Al-Qahtani), College of Medicine; from the Department of Surgery (Abuhaimed), King Saud University; and from the Department of Otorhinolaryngology Head and Neck Surgery (Altuwaijri, Bedaiwi, Almayouf, Albarrak, Al-Qahtani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia
1 shared publicationKhalid H. Al-Qahtani
From the Department of Otolaryngology-Head and Neck Surgery (Altuwaijri Alessa, Aldhahri, Al-Qahtani), College of Medicine; from the Department of Surgery (Abuhaimed), King Saud University; and from the Department of Otorhinolaryngology Head and Neck Surgery (Altuwaijri, Bedaiwi, Almayouf, Albarrak, Al-Qahtani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia
1 shared publicationMajed M. Albarrak
From the Department of Otolaryngology-Head and Neck Surgery (Altuwaijri Alessa, Aldhahri, Al-Qahtani), College of Medicine; from the Department of Surgery (Abuhaimed), King Saud University; and from the Department of Otorhinolaryngology Head and Neck Surgery (Altuwaijri, Bedaiwi, Almayouf, Albarrak, Al-Qahtani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia
1 shared publicationMohammad A. Almayouf
From the Department of Otolaryngology-Head and Neck Surgery (Altuwaijri Alessa, Aldhahri, Al-Qahtani), College of Medicine; from the Department of Surgery (Abuhaimed), King Saud University; and from the Department of Otorhinolaryngology Head and Neck Surgery (Altuwaijri, Bedaiwi, Almayouf, Albarrak, Al-Qahtani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia
1 shared publicationMohammed A. Alessa
From the Department of Otolaryngology-Head and Neck Surgery (Altuwaijri Alessa, Aldhahri, Al-Qahtani), College of Medicine; from the Department of Surgery (Abuhaimed), King Saud University; and from the Department of Otorhinolaryngology Head and Neck Surgery (Altuwaijri, Bedaiwi, Almayouf, Albarrak, Al-Qahtani), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia
1 shared publication
Latest Publications
- 1 October 2022
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 74 (SUPPL 2) , 1514-1517
Alar Cartilage Hematoma: Case Report and Literature Review
- 1 October 2022
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 74 (SUPPL 2) , 1514-1517
Alar Cartilage Hematoma: Case Report and Literature Review
- Open Access
- 7 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20255
Prevalence of Metastasis and Involvement of Level IV and V in Oral Squamous Cell Carcinoma: A Systematic Review
The occurrence of occult metastases in oral cavity squamous cell carcinoma (OSCC) to lower levels in the neck (levels IV and V) or development of skip metastases that bypass the upper neck levels (levels I to III) and go directly to level IV or V is common. This challenges the efficacy of conventional neck dissection approaches in the treatment of OSCC. Therefore, the decision to include lower levels cervical nodes during elective neck dissection of OSCC remains controversial. This systematic review was designed to assess the prevalence of level IV and/or V involvement or skip metastases in patients with the clinically negative neck (cN0) or positive (cN+) oral squamous cell carcinoma (OSCC). We searched for studies published between December 2000 and December 2020. Potentially relevant abstracts and full-text articles were screened, and data from the studies were extracted. Quality was rated using the Newcastle Ottawa Scale (NOS) criteria. In total, 802 abstracts and 227 full-text articles were screened, and 32 studies were included in this analysis. The prevalence of metastasis ranged from 1.8% to 66.0%. The incidence for skip metastasis to level IV or V was low, reaching 8.5%. Evidence favored elective neck dissection, including levels I to III, in selected patients with OSCC and patients with cN0 or cN+ neck. The literature was non-conclusive on the recommendation for inclusion of lower levels.
- 7 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20255
Open AccessPrevalence of Metastasis and Involvement of Level IV and V in Oral Squamous Cell Carcinoma: A Systematic Review
The occurrence of occult metastases in oral cavity squamous cell carcinoma (OSCC) to lower levels in the neck (levels IV and V) or development of skip metastases that bypass the upper neck levels (levels I to III) and go directly to level IV or V is common. This challenges the efficacy of conventional neck dissection approaches in the treatment of OSCC. Therefore, the decision to include lower levels cervical nodes during elective neck dissection of OSCC remains controversial. This systematic review was designed to assess the prevalence of level IV and/or V involvement or skip metastases in patients with the clinically negative neck (cN0) or positive (cN+) oral squamous cell carcinoma (OSCC). We searched for studies published between December 2000 and December 2020. Potentially relevant abstracts and full-text articles were screened, and data from the studies were extracted. Quality was rated using the Newcastle Ottawa Scale (NOS) criteria. In total, 802 abstracts and 227 full-text articles were screened, and 32 studies were included in this analysis. The prevalence of metastasis ranged from 1.8% to 66.0%. The incidence for skip metastasis to level IV or V was low, reaching 8.5%. Evidence favored elective neck dissection, including levels I to III, in selected patients with OSCC and patients with cN0 or cN+ neck. The literature was non-conclusive on the recommendation for inclusion of lower levels.
- Open Access
- 1 December 2021
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 42 (12) , 1357-1361
Lymph node yield as a prognostic factor in clinically node negative oral cavity squamous cell carcinoma
Objectives: To determine the prognostic significance of nodal yield in patients with clinically node-negative (cN0) oral cavity squamous cell carcinoma (OCSCC). Methods: This retrospective observational study included 40 patients with cN0 OCSCC who underwent treatment with at least 6 months of follow-up data from November 2012 to April 2020. We recorded the variables, including patient demographics, cancer site, tumor-node-metastasis (TNM) staging, type of treatment, lymph node yield (LNY), histopathologic diagnosis, and recurrence. The recorded data were analyzed with descriptive and interferential statistics using specific tests. Results: Our study cohort comprised of 27 males and 13 females with a mean age of 60.08+13.153 years. Tongue (55%) was the commonly affected site. Seventeen (42.5%) patients belonged to TNM stage II. The mean LNY in our study was 38.65±25.41 (range 7-98). Following surgery, 19 (47.5%) patients further received adjuvant therapies. Recurrence was reported only in 4 (10%) patients. There was no significant difference between LNY and recurrence rate (p=0.892). Factors including, age (p=0.121), gender (p=0.209), site (p=0.519), size of tumor (p=0.416) did not influence the LNY. Conclusion: There is no correlation between LNY and recurrence in cN0 OCSCC patients in our study. Meticulous neck dissection and thorough pathologic reporting prevents TNM under staging and improves the overall survival and prognosis.
- 1 December 2021
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 42 (12) , 1357-1361
Open AccessLymph node yield as a prognostic factor in clinically node negative oral cavity squamous cell carcinoma
Objectives: To determine the prognostic significance of nodal yield in patients with clinically node-negative (cN0) oral cavity squamous cell carcinoma (OCSCC). Methods: This retrospective observational study included 40 patients with cN0 OCSCC who underwent treatment with at least 6 months of follow-up data from November 2012 to April 2020. We recorded the variables, including patient demographics, cancer site, tumor-node-metastasis (TNM) staging, type of treatment, lymph node yield (LNY), histopathologic diagnosis, and recurrence. The recorded data were analyzed with descriptive and interferential statistics using specific tests. Results: Our study cohort comprised of 27 males and 13 females with a mean age of 60.08+13.153 years. Tongue (55%) was the commonly affected site. Seventeen (42.5%) patients belonged to TNM stage II. The mean LNY in our study was 38.65±25.41 (range 7-98). Following surgery, 19 (47.5%) patients further received adjuvant therapies. Recurrence was reported only in 4 (10%) patients. There was no significant difference between LNY and recurrence rate (p=0.892). Factors including, age (p=0.121), gender (p=0.209), site (p=0.519), size of tumor (p=0.416) did not influence the LNY. Conclusion: There is no correlation between LNY and recurrence in cN0 OCSCC patients in our study. Meticulous neck dissection and thorough pathologic reporting prevents TNM under staging and improves the overall survival and prognosis.